Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Fluoxetine Buspirone

The effects of buspirone are decreased when the drug is administered with fluoxetine Increased serum levels of buspirone occur if the drug is taken with erythromycin or itraconazole Should any of these combinations be required, the dosage of buspirone is decreased to 2.5 mg BID, and the patient is monitored closely. Venlafaxine blood levels increase with a risk of toxicity when administered witii MAOIs or cimetidine There is an increased risk of toxicity when trazodone is administered with the phenothiazines and decreased effectiveness of trazodone when it is administered with carbamazepine Increased serum digoxin levels have occurred when digoxin is administered with trazodone There is a risk for increased phenytoin levels when phenytoin is administered witii trazodone... [Pg.287]

Kranzler HR, Del Boca F, Korner P, et ah Adverse effects limit the usefulness of flu-voxamine for the treatment of alcoholism.] Subst Abuse Treat 10 283-287, 1993 Kranzler HR, Burleson JA, Del Boca FK, et ah Buspirone treatment of anxious alcoholics a placebo-controlled trial. Arch Gen Psychiatry 31 720—731, 1994 Kranzler HR, Burleson JA, Korner P, et ah Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am] Psychiatry 152 391-397, 1995 Kranzler HR, Burleson JA, Brown J, et al Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin Exp Res 20 1534-1341, 1996... [Pg.48]

We have not explored all of the dose-response relationships. And with respect to the nature of the cue, we have studies underway now with a variety of serotonin agonists and antagonists, for example, fluoxetine. And have looked at MDMA. We eannot bloek the cue with fluoxetine. We are also looking at 8-hydroxy-DPAT, buspirone. PCPA pretreatment is on the way. So there are a variety of manipulations that we have in process. [Pg.21]

Maprotiline, Moclobemide, Mianserin, Fluoxetine (Prozac), Paroxetine, Sertraline, Fluvoxamine, Citalopram, Venlafaxin (generic IR formulation and the brand Venlafaxine XR), Mirtazapine, Flupentixol-melitracen (Deanxit), Tianeptine, Extract of St. John s Wort, Buspirone Depression and anxiety... [Pg.89]

Buspirone (BuSpar) [Anxiolytic] WARNING Closely monitor for worsening depression or emergence of suicidality Uses Short-term relief of anxiety Action Antianxiety antagonizes CNS serotonin receptors Dose Initial 7.5 mg PO bid T by 5 mg q2-3d to effect usual 20-30 mg/d max 60 mg/d Contra w/ MAOI Caution [B, /-] Avoid w/ severe hepatic/renal insuff Disp Tabs SE Drowsiness, dizziness, HA, N, EPS, serotonin synd, hostility, depression Notes No abuse potential or physical/psychologic d endence Interactions T Effects W/ erythromycin, clarithromycin, itraconazole, ketoconazole, diltiazem, verapamil, grapefruit juice effects W/ carbamazepine, rifampin, phenytoin, dexamethasone, phenobarbital, fluoxetine EMS T Sedation w/ concurrent EtOH use grapefruit juice may T risk of adverse effects OD May cause dizziness, miosis, N/V symptomatic and supportive... [Pg.95]

Bakish D Fluoxetine potentiation by Buspirone three case histories. Can J Psychiatry 36 749-750, 1991... [Pg.591]

Grady TA, Pigott TA, L Heureux E, et al Seizure associated with fluoxetine and adjuvant buspirone therapy [letter). J Clin Psychopharmacol 12 70-71, 1992... [Pg.648]

Grady TA, Pigott TA, L Heureux PL, et al Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. Am J Psychiatry 150 819-821, 1993... [Pg.648]

Jenike MA, Baer L, Buttolph L Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder. J Clin Psychiatry 52 13-14, 1991a Jenike MA, Baer L, Ballantine HT, et al Cingulotomy for refractory obsessive-compulsive disorder a long-term follow-up of 33 patients. Arch Gen Psychiatry 48 548-555, 1991b... [Pg.666]

Markovitz PJ, Stagno SJ, Calabrese JR Buspirone augmentation of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry 147 798-800, 1990 Markowitz JS, Weissman PH, Ouelette R, et al Quality of life in panic disorder. Arch Gen Psychiatry 46 984-992, 1989... [Pg.691]

Treatment of GAD can be undertaken using a number of pharmacological agents. Benzodiazepines have been found to be superior to placebo in several studies and all benzodiazepines appear to be equally effective. However, side effects include sedation, psvchomotor impairment, amnesia and tolerance (Chapter 1). Recent clinical data indicate that SSRIs and SNRIs are effective in the treatment of acute GAD symptoms. Venlafaxine, paroxetine and imipramine have been shown to be effective antianxiety medications in placebo-controlled studies. Case studies also indicate the usefulness of clomipramine, nefazodone, mirtazapine, fluoxetine and fluvoxamine in GAD. Buspirone, a 5-HTla receptor partial agonist, has been shown to be effective in several placebo-controlled, double-blind trials (Roy-Byme and Cowley, 2002). Buspirone has a later onset of action than both benzodiazepines and SSRIs but with the advantage of being non-addictive and non-sedating. [Pg.293]

Manos GH. Possible serotonin syndrome associated with buspirone added to fluoxetine. Ann Pharmacother 2000 34(7-8) 871-4. [Pg.52]

Omeprazole, like cimetidine, can impair benzodiazepine metabolism and lead to adverse effects (SEDA-18, 43). Other drugs, including antibiotics (erythromycin, chloramphenicol, isoniazid), antifungal drugs (ketoconazole, itraconazole, and analogues), some SSRIs (fluoxetine, paroxetine), other antidepressants (nefazodone), protease inhibitors (saquinavir), opioids (fentanyl), calcium channel blockers (diltiazem, verapamil), and disulfiram also compete for hepatic oxidative pathways that metabolize most benzodiazepines, as well as zolpidem, zopiclone, and buspirone (SEDA-22,39) (SEDA-22,41). [Pg.447]

Some SSRIs (notably fluvoxamine and to a lesser extent fluoxetine) and their metabohtes inhibit hepatic oxidative enzymes, particularly CYP2C19 and CYP3A, that metabolize most benzodiazepines, as well as zaleplon, zolpidem, zopiclone, and buspirone (SEDA-22, 39) (SEDA-22, 41) (168,169). Apart from fluvoxamine, SSRIs do not generally have a chnically prominent effect on hypnosedative effects studies vary from those that have found that fluoxetine has a moderate but functionally unimportant impact on diazepam concentrations (170) to results that suggest significant aggravation of the cognitive effects of alprazolam when co-prescribed with the SSRI (171). [Pg.438]

Proof-of-concept studies have demonstrated that lOOx Cmax is a reasonable scaling factor to differentiate hepatotoxic (or positive) versus nontoxic (or negative) drugs.108 For example, in a family of antidepressant drugs, nefazodone was consistently positive, whereas buspirone and fluoxetine remained negative, but all tested at 100x of their respective single-dose therapeutic Cmax.108... [Pg.67]

Buspirone An isolated report describes the development of the serotonin syndrome with bus-pirone and citalopram-, the same may happen with fluvoxamine. Busprone with fluoxetine can be effective, but some adverse reactions have been reported. Fluvoxamine may possibly reduce the effects of buspirone. [Pg.2473]


See other pages where Fluoxetine Buspirone is mentioned: [Pg.266]    [Pg.266]    [Pg.199]    [Pg.483]    [Pg.54]    [Pg.148]    [Pg.116]    [Pg.1024]    [Pg.318]    [Pg.183]    [Pg.443]    [Pg.482]    [Pg.500]    [Pg.500]    [Pg.300]    [Pg.487]    [Pg.719]    [Pg.742]    [Pg.755]    [Pg.23]    [Pg.142]    [Pg.95]    [Pg.547]    [Pg.148]    [Pg.194]    [Pg.386]    [Pg.48]    [Pg.1041]   
See also in sourсe #XX -- [ Pg.743 ]




SEARCH



Fluoxetin

Fluoxetine

© 2024 chempedia.info